G
GLP1Cost

Zepbound vs Foundayo (orforglipron)

By Anthony K C Fong, Esq.·Last reviewed:
NY State Bar #5361159 · Hawaii State Bar · Founder, GLP1Cost.org

Side-by-side comparison based on SURMOUNT-1 and ATTAIN-1 phase 3 trial data plus May 2026 pricing.

Zepbound
tirzepatide (injection)
Higher efficacy
Peak weight loss22.5%
TrialSURMOUNT-1
Administrationinjection
FDA statusweight-loss
List price$1,059/mo
Foundayo (orforglipron)
orforglipron (tablet)
Peak weight loss14.7%
TrialATTAIN-1
Administrationoral
FDA statusweight-loss
List price$1,099/mo

Weight loss comparison (220 lbs starting weight)

% of body weight lost over 18 months, modeled from phase 3 trial data

Monthly cost by payment channel

ChannelZepboundFoundayo (orforglipron)Difference
Covered by insurance ($25–150 copay)$88$63$25 (Foundayo (orforglipron) cheaper)
Manufacturer self-pay (LillyDirect / NovoCare)$299$149$150 (Foundayo (orforglipron) cheaper)
Telehealth: brand name (Hims, Ro, Found)$499--
Cash retail (full list price)$1,059$1,099$40 (Zepbound cheaper)

Zepbound pros and cons

Pros
  • Highest efficacy of any FDA-approved GLP-1 (22.5% in SURMOUNT-1)
  • Dual GLP-1/GIP mechanism
  • LillyDirect self-pay vials starting around $349/mo for lower doses
  • FDA-approved for chronic weight management
Cons
  • List price still high ($1,059/mo)
  • Insurance coverage varies more than for Wegovy
  • GI side effects can be more pronounced at higher doses
  • Periodic supply constraints during demand spikes

Foundayo (orforglipron) pros and cons

Pros
  • Daily pill with NO food or water restrictions (advantage over oral Wegovy 25 mg)
  • Non-peptide small molecule - easier manufacturing and scaling
  • 14.7% average weight loss in ATTAIN-1
  • LillyDirect self-pay starts at $149/mo for the lowest dose
  • Medicare Part D coverage as low as $50/mo beginning July 1, 2026
Cons
  • New molecule (April 2026 approval) - limited real-world safety data outside trials
  • Daily adherence required
  • Higher doses (14.5/17.2 mg) price up to $349/mo out of refill window

Common side effects

Zepbound
  • Nausea
  • Diarrhea
  • Constipation
  • Vomiting
  • Decreased appetite
Foundayo (orforglipron)
  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation

Which should you choose: Zepbound or Foundayo (orforglipron)?

Choose Zepbound if: you want maximum weight loss (22.5% vs 14.7%); you prefer a weekly injection over a daily pill; cash-pay cost matters most to you.

Choose Foundayo (orforglipron) if: you prefer a daily pill over a weekly injection.

Final decisions should always be made with a licensed prescriber. This is educational content only.

Affiliate disclosure: This page contains affiliate links. We may earn a commission if you click through and complete a qualifying action. Your price does not change. Affiliate revenue does not influence our pricing data or rankings - full disclosure.

Where to actually buy Zepbound or Foundayo (orforglipron) (and the alternatives)

Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.

DrugInsuranceMfr directTelehealth (brand)Telehealth (compd)Cash retailGet it
Wegovy
14.9% weight loss
$63$349$329$249
cheapest
$1,349Get →
Ozempic
11.6% weight loss
$63-$399$199
cheapest
$998Get →
Wegovy (oral 25mg)
13.6% weight loss
$63$149
cheapest
$449-$1,349Get →
Zepbound
22.5% weight loss
$88$299
cheapest
$499$299
cheapest
$1,059Get →
Mounjaro
20.9% weight loss
$88-$499$299
cheapest
$1,069Get →
Saxenda
8.4% weight loss
$63-$399
cheapest
-$1,349Get →
Foundayo (orforglipron)
14.7% weight loss
$63$149
cheapest
--$1,099Get →
Some links are affiliate. We earn a commission at no cost to you. We never recommend a product based on commission. Disclaimer.
Run your own projection on the full calculator →
Medical disclaimer: This calculator provides estimates only based on phase 3 clinical trial data and publicly listed prices. It is not medical advice. Real-world weight loss varies significantly. Consult a licensed healthcare provider before starting any medication.

More comparisons

Related guides

💸 Find your cheapest GLP-1 →